Andujar, Relaine C.

HRN: 23-63-16  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2023
CEFUROXIME 1.5GM (VIAL)
10/14/2023
10/14/2023
IV
1.5 G
Once PTOR
For Elective CS With BTL
Waiting Final Action 
10/14/2023
CEFUROXIME 1.5GM (VIAL)
10/14/2023
10/16/2023
IV
1.5
Q8
CS With BTL
Waiting Final Action 
10/15/2023
CEFUROXIME 500MG (TAB)
10/15/2023
10/21/2023
PO
1 Tab
BID
S/p LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: